% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{MoralesBerstein:179790,
      author       = {F. Morales Berstein and D. L. McCartney and A. T. Lu and K.
                      K. Tsilidis and E. Bouras and P. Haycock and K. Burrows and
                      A. I. Phipps and D. D. Buchanan and I. Cheng and R. M.
                      Martin and G. Davey Smith and C. L. Relton and S. Horvath
                      and R. E. Marioni and T. G. Richardson and R. C. Richmond
                      and R. A. Eeles and C. A. Haiman and Z. Kote-Jarai and F. R.
                      Schumacher and S. Benlloch and A. A. Al Olama and K. R. Muir
                      and S. I. Berndt and D. V. Conti and F. Wiklund and S.
                      Chanock and Y. Wang and C. M. Tangen and J. Batra and J. A.
                      Clements and Apcb BioResource Australian Prostate Cancer
                      BioResource and H. Grönberg and N. Pashayan and J.
                      Schleutker and D. Albanes and S. Weinstein and A. Wolk and
                      C. M. L. West and L. A. Mucci and G. Cancel-Tassin and S.
                      Koutros and K. D. Sørensen and E. M. Grindedal and D. E.
                      Neal and F. C. Hamdy and J. L. Donovan and R. C. Travis and
                      R. J. Hamilton and S. A. Ingles and B. S. Rosenstein and
                      Y.-J. Lu and G. G. Giles and R. J. MacInnis and A. S. Kibel
                      and A. Vega and M. Kogevinas and K. L. Penney and J. Y. Park
                      and J. L. Stanford and C. Cybulski and B. G. Nordestgaard
                      and S. F. Nielsen and H. Brenner$^*$ and C. Maier and U. Kim
                      and E. M. John and M. R. Teixeira and S. L. Neuhausen and K.
                      De Ruyck and A. Razack and L. F. Newcomb and D. Lessel and
                      R. Kaneva and N. Usmani and F. Claessens and P. A. Townsend
                      and J. Esteban Castelao and M. J. Roobol and F. Menegaux and
                      K.-T. Khaw and U. Cannon-Albright and H. Pandha and S. N.
                      Thibodeau and D. J. Hunter and P. Kraft and W. J. Blot and
                      E. Riboli},
      collaboration = {P. consortium},
      title        = {{A}ssessing the causal role of epigenetic clocks in the
                      development of multiple cancers: a {M}endelian randomization
                      study.},
      journal      = {eLife},
      volume       = {11},
      issn         = {2050-084X},
      address      = {Cambridge},
      publisher    = {eLife Sciences Publications},
      reportid     = {DKFZ-2022-00897},
      pages        = {e75374},
      year         = {2022},
      abstract     = {Epigenetic clocks have been associated with cancer risk in
                      several observational studies. Nevertheless, it is unclear
                      whether they play a causal role in cancer risk or if they
                      act as a non-causal biomarker.We conducted a two-sample
                      Mendelian randomization (MR) study to examine the
                      genetically predicted effects of epigenetic age acceleration
                      as measured by HannumAge (nine single-nucleotide
                      polymorphisms (SNPs)), Horvath Intrinsic Age (24 SNPs),
                      PhenoAge (11 SNPs), and GrimAge (4 SNPs) on multiple cancers
                      (i.e. breast, prostate, colorectal, ovarian and lung
                      cancer). We obtained genome-wide association data for
                      biological ageing from a meta-analysis (N = 34,710), and for
                      cancer from the UK Biobank (N cases = 2671-13,879; N
                      controls = 173,493-372,016), FinnGen (N cases = 719-8401; N
                      controls = 74,685-174,006) and several international cancer
                      genetic consortia (N cases = 11,348-122,977; N controls =
                      15,861-105,974). Main analyses were performed using
                      multiplicative random effects inverse variance weighted
                      (IVW) MR. Individual study estimates were pooled using fixed
                      effect meta-analysis. Sensitivity analyses included
                      MR-Egger, weighted median, weighted mode and Causal Analysis
                      using Summary Effect Estimates (CAUSE) methods, which are
                      robust to some of the assumptions of the IVW
                      approach.Meta-analysed IVW MR findings suggested that higher
                      GrimAge acceleration increased the risk of colorectal cancer
                      (OR = 1.12 per year increase in GrimAge acceleration, $95\%$
                      CI 1.04-1.20, p = 0.002). The direction of the genetically
                      predicted effects was consistent across main and sensitivity
                      MR analyses. Among subtypes, the genetically predicted
                      effect of GrimAge acceleration was greater for colon cancer
                      (IVW OR = 1.15, $95\%$ CI 1.09-1.21, p = 0.006), than rectal
                      cancer (IVW OR = 1.05, $95\%$ CI 0.97-1.13, p = 0.24).
                      Results were less consistent for associations between other
                      epigenetic clocks and cancers.GrimAge acceleration may
                      increase the risk of colorectal cancer. Findings for other
                      clocks and cancers were inconsistent. Further work is
                      required to investigate the potential mechanisms underlying
                      the results.FMB was supported by a Wellcome Trust PhD
                      studentship in Molecular, Genetic and Lifecourse
                      Epidemiology (224982/Z/22/Z which is part of grant
                      218495/Z/19/Z). KKT was supported by a Cancer Research UK
                      (C18281/A29019) programme grant (the Integrative Cancer
                      Epidemiology Programme) and by the Hellenic Republic's
                      Operational Programme 'Competitiveness, Entrepreneurship
                      $\&$ Innovation' (OΠΣ 5047228). PH was supported by Cancer
                      Research UK (C18281/A29019). RMM was supported by the NIHR
                      Biomedical Research Centre at University Hospitals Bristol
                      and Weston NHS Foundation Trust and the University of
                      Bristol and by a Cancer Research UK (C18281/A29019)
                      programme grant (the Integrative Cancer Epidemiology
                      Programme). RMM is a National Institute for Health Research
                      Senior Investigator (NIHR202411). The views expressed are
                      those of the author(s) and not necessarily those of the NIHR
                      or the Department of Health and Social Care. GDS and CLR
                      were supported by the Medical Research Council
                      $(MC_UU_00011/1$ and $MC_UU_00011/5,$ respectively) and by a
                      Cancer Research UK (C18281/A29019) programme grant (the
                      Integrative Cancer Epidemiology Programme). REM was
                      supported by an Alzheimer's Society project grant
                      (AS-PG-19b-010) and NIH grant (U01 AG-18-018, PI: Steve
                      Horvath). RCR is a de Pass Vice Chancellor's Research Fellow
                      at the University of Bristol.},
      keywords     = {Colorectal Neoplasms: epidemiology / Colorectal Neoplasms:
                      genetics / Epigenesis, Genetic / Genome-Wide Association
                      Study: methods / Humans / Male / Mendelian Randomization
                      Analysis / Polymorphism, Single Nucleotide / DNA methylation
                      (Other) / Mendelian randomization (Other) / cancer (Other) /
                      epidemiology (Other) / epigenetic age acceleration (Other) /
                      epigenetic clocks (Other) / genetics (Other) / genomics
                      (Other) / human (Other) / medicine (Other)},
      cin          = {C070 / C120 / HD01},
      ddc          = {600},
      cid          = {I:(DE-He78)C070-20160331 / I:(DE-He78)C120-20160331 /
                      I:(DE-He78)HD01-20160331},
      pnm          = {313 - Krebsrisikofaktoren und Prävention (POF4-313)},
      pid          = {G:(DE-HGF)POF4-313},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:35346416},
      pmc          = {pmc:PMC9049976},
      doi          = {10.7554/eLife.75374},
      url          = {https://inrepo02.dkfz.de/record/179790},
}